Aviceda Therapeutics

1 follower


Aviceda Therapeutics is a late-stage, pre-clinical stage biotech company focused on the next generation of immuno-modulators by harnessing the power of glycobiology to address the innate immune system and chronic non-resolving inflammation specifically and profoundly.

Industries

Employees

11-50

Links

Org chart

David Callanan
SVP & Chief Medical Officer
Derek Kunimoto
Co-Founder & Chief Strategy Officer
Michael Tolentino
Co-Founder, CTO
Tarek S. Hassan
SVP & Chief Development Officer
Mike Guo
SVP, Business Development & Corporate Strategy